Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Noble Romans (NROM) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Noble Romans (NROM) over the last 15 years, with Q3 2025 value amounting to $26.0 million.

  • Noble Romans' Shares Outstanding (Diluted Average) rose 655.61% to $26.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.0 million, marking a year-over-year increase of 655.61%. This contributed to the annual value of $24.3 million for FY2024, which is 301.02% up from last year.
  • Noble Romans' Shares Outstanding (Diluted Average) amounted to $26.0 million in Q3 2025, which was up 655.61% from $25.0 million recorded in Q2 2025.
  • Noble Romans' 5-year Shares Outstanding (Diluted Average) high stood at $26.0 million for Q3 2025, and its period low was $22.2 million during Q4 2022.
  • For the 5-year period, Noble Romans' Shares Outstanding (Diluted Average) averaged around $23.8 million, with its median value being $23.6 million (2023).
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first plummeted by 603.24% in 2022, then skyrocketed by 1378.95% in 2025.
  • Noble Romans' Shares Outstanding (Diluted Average) (Quarter) stood at $23.6 million in 2021, then dropped by 6.03% to $22.2 million in 2022, then grew by 6.23% to $23.6 million in 2023, then rose by 3.01% to $24.3 million in 2024, then increased by 6.81% to $26.0 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $26.0 million for Q3 2025, versus $25.0 million for Q2 2025 and $25.3 million for Q1 2025.